Translation. Region: Russian Federal
Source: Rosneft – Rosneft – An important disclaimer is at the bottom of this article.
The Center for Whole Genome Sequencing of Biotechnology Campus LLC (hereinafter referred to as the Center) has fulfilled the plan for collecting biomaterials within the framework of the national genetic initiative “100,000 I”. The total number of samples has exceeded 100,000 units, of which more than 80,000 have already been decoded and entered into the project database. Full processing of the collected genomes will be completed by the end of the year.
The 100,000 I project is being implemented by the Center within the framework of the Federal Scientific and Technical Program for the Development of Genetic Technologies, the main technological partner of which is PJSC NK Rosneft. The main objective of the initiative is to decipher and systematize the genomes of Russian residents to identify hereditary predisposition to serious diseases.
At the current stage of research, scientists have already identified the genetic causes of diseases in more than 10,000 patients. Bioinformatics analysis has identified thousands of unique genetic variants associated with 500 different rare (orphan) diseases.
In addition, based on the analysis of more than 50,000 genomes of the initiative’s volunteers, reference data on the genetic diversity of the Russian population has been formed – the so-called “genomic landscape”. These data will become the starting point for further work, which scientists will be able to rely on to identify new patterns in human DNA.
Additionally, samples of over 5,000 representatives of 50 different nationalities of the Russian Federation were analyzed. To assess the frequency of genetic variants that lead to severe genetic diseases, in certain regions, for example, in Yakutia or in the regions of the North Caucasus Federal District, expanded studies of representatives of individual ethnic communities are being conducted. Their results will form the basis for genetic screening programs for healthy family planning and prevention of hereditary pathologies.
The implementation of the “100,000 I” initiative makes a significant contribution to the development of personalized medicine and prevention of hereditary diseases in the country. The center cooperates with leading medical and genetic research centers, including: Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Academician B.V. Petrovsky Russian Scientific Center of Surgery, Academician N.P. Bochkov Medical and Genetic Research Center, Ufa Federal Research Institute and many others.
Rosneft pays special attention to the development of the scientific and educational part of the project. Together with Rosneft, master’s programs in genetics have been developed and launched at Moscow State University and Moscow Institute of Physics and Technology: “Genomics and Human Health” and “Algorithmic Biology”, respectively. During the training, students of the programs undergo practical training at the Center’s sites, and after successfully mastering the specialty and graduating, they have the opportunity to find employment there. The formation of a personnel reserve and the development of the scientific infrastructure of the project create the basis for further progress in the field of genetic technologies in Russia.
Specialists from the Biotechnology Campus regularly participate in educational events. In particular, in 2023-2024 they gave lectures and presentations at the Rosneft pavilion as part of the international exhibition and forum Russia at VDNKh.
Department of Information and Advertising of PJSC NK Rosneft June 11, 2025
Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.